Comparing results of different volumes of hydrodilatation for frozen shoulder
Official title: Comparision of Hydrodilatation Results at Different Volumes in Adhesive Capsulitis by Phases.
Run by Maimónides Biomedical Research Institute of Córdoba · NCT06939530 · Data updated 2026-11-12
This study is testing whether using more or less fluid in a treatment for frozen shoulder helps people feel better and move their shoulder more easily.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 30 Years to 70 Years |
| Sex | All |
| Enrollment | 64 (estimated) |
| Sponsor | Maimónides Biomedical Research Institute of Córdoba Academic / other |
| Locations | 1 site (Córdoba) |
| Status | Recruiting |
| Started | February 2, 2025 |
| Main results expected | January 2026 |
| Study ends | January 2026 |
| Registry record updated | April 23, 2025 |
| Trial ID | NCT06939530 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 30 to 70 with limited shoulder range of motion and pain lasting more than three months.
✕Probably not a fit
Patients with conditions that mimic adhesive capsulitis or those who have had recent treatments that may affect their shoulder function may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of high-volume versus low-volume hydrodilatation in patients with adhesive capsulitis, also known as frozen shoulder. Participants will be stratified by the phase of their condition and will receive either 20 ml or 40 ml of hydrodilatation treatment. Outcomes will be measured using the Shoulder Pain and Disability Index (SPADI), Visual Analogue Scale (VAS), and range of motion (ROM) assessments at one, three, and six months post-treatment. The goal is to determine which volume of hydrodilatation yields better results in alleviating symptoms and improving shoulder function.
Why it matters
Potential benefit: If successful, this study could provide clearer guidelines for treating adhesive capsulitis, leading to improved patient outcomes and reduced pain.
How similar studies have gone: Previous studies have shown varying success with hydrodilatation for adhesive capsulitis, but this specific comparison of volume is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ages between 30 and 70 years. * Limited ROM, both active and passive, in two planes. * Shoulder pain lasting more than 3 months. Exclusion Criteria: * Lidocaine + trial with improved ROM. * Conditions that preclude treatment (active cancer, tissue infection, oral anticoagulant use, cardiac arrhythmias, etc.) * Previously receiving HD treatment in less than 1 year. * Stage 0 or 3 AC. * Non-adherence to the PT program, with attendance failures exceeding 20%. * Presence of conditions that can cause similar symptoms, such as acromioclavicular osteoarthritis, labral injury, massive rotator cuff tear, or rheumatic diseases. * Intra-articular corticosteroid injection in less than 2 months. * Technique failure.
Where it's running
-
Hospital Universitario Reina Sofia
Córdoba, Spain Recruiting
Study contacts
- Principal investigator: Javier Muñoz Paz, degree in medicine — Hospital Universitario Reina Sofia de Cordoba
- Study coordinator: Javier Muñoz Paz, degree in medicine
- Email: javimp1395@gmail.com
- Phone: 608737909
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
TaVNS added to physiotherapy for adhesive capsulitis
This study tests whether adding a tVNS treatment to standard physiotherapy helps adults with adhesive capsulitis reduce pain and improve shoulder function.
-
Nexsphere-F arterial embolization for chronic frozen shoulder pain
We will try a minimally invasive arterial embolization using Nexsphere-F to reduce pain in adults with frozen shoulder that hasn’t improved with usual care.
-
Hormone Replacement Therapy added to standard care for frozen shoulder in peri- or postmenopausal women
This study tests whether adding hormone replacement therapy to standard treatment helps reduce pain and stiffness from frozen shoulder in peri- or postmenopausal women.
-
Comparing two doses of corticosteroids for frozen shoulder treatment
This study is testing whether two different doses of a steroid injection can help people with frozen shoulder feel less pain and move their shoulder better.
-
Evaluating non-invasive neurostimulation for frozen shoulder treatment
This study is testing if a new non-invasive treatment using brain stimulation and tendon vibration can help people with frozen shoulder feel better compared to a placebo.
-
Evaluating robotic training for shoulder adhesive capsulitis
This study is testing if robotic training can help adults with shoulder pain and movement issues recover better than regular rehab methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.